BeiGene, Lilly target big markets

By Megan Brodie 1 month ago | In Regulatory
  • 1 month ago
Lilly is targeting Sanofi's blockbuster with its new eczema therapy.

3 June 2024 It took the company almost two years but BeiGene has finally secured…

This is subscriber-only content. Please login to continue reading.